I have used them in the past and every time without fail the price has immediately shot back up again and I have regretted it. On the other hand I have picked up some cheap shares by using limit orders in the same way.
I do have SNG but less than a tenth of what I have invested in NYCT. I believe that there are greater things to come for NYCT as it's becoming more obvious day by day that Covid isn't going to go away very quickly.
Saintsmith, I have done it the other way, left it too long and the stock has gone down. I'm happy with my profit on SNG for the small amount I have invested. Fingers crossed NCYT does the same as I have a lot (for me) riding on this one.
The RNS mentioned the strong cash position is after significant investment to meet expected demand in the second half of the year so I am mainly in agreement with Bluelight. However they will still have cash going out during the rest of the year for further future expected demand.
I have two friends with daughters aged in late teens and early 20's. They say there is a constant supply of parcels coming from various companies like Pretty Little Thing - they wear something and once they have been seen in it (particularly on social media) they won't wear it again. It's why companies like this thrive, the youngsters buy cheap then throw it. And I don't believe either of the girls will even think about how it's made to be honest.
Only around one-third of individuals testing positive for COVID-19 on a swab test reported having symptoms
The analysis of those reporting evidence of symptoms appears to show that those reporting symptoms are much more likely to have contracted the virus. However, additional analysis shows that, of those who tested positive, only 33% (95% confidence interval: 25% to 43%) reported any evidence of symptoms at the time of their swab test or at either the preceding or subsequent swab test. The share fell to 22% of those testing positive when accounting for those who reported evidence of symptoms only at the time of their swab test.
The remaining 67% of positive cases either did not report having any of the specific or general symptoms on the day of their positive swab test, preceding swab test or subsequent swab test, or did not answer both questions. While this suggests there is a potentially large number of asymptomatic cases, it is important to note that symptoms were self-reported rather than professionally diagnosed, and those without any evidence of symptoms will include instances where the questions relating to symptoms were not answered.
Source: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/july2020?fbclid=IwAR0G4XlsZVf7NVfHg9etTjCOAW47X7OQdJNNckpkaEb-5djxXLBAncvHgdI
Chrishar - as whatnonewsyet said. It's in the RNS dated 3rd June.
Admission to Trading & Total Voting Rights
Application will be made for 2,952,681 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective at 8.00 a.m. on or around 9 June 2020. Admission of the new Ordinary Shares to trading on Euronext is expected to occur on or before 9 June 2020.
Following Admission, the total number of shares in the Company is 70,626,248. This figure may be used by shareholders as the denominator for calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company pursuant to Article L. 233-7 of the French Commercial Code and the Company's Articles.
PROP5, I was accused of de ramping when I said a friend was part of a trial test over here and it wasn't ours they were using. I have too much money invested this to be de ramping, but IMO it is useful to know the facts.
Interesting article on why the antibody test is not stand alone. https://www.dailymail.co.uk/health/article-8417409/Am-proof-people-never-immune-Covid-19.html